A population based case-control study of oral moroxydine, an antiviral agent treatment during pregnancy

International Journal of Pharmacology

Volumn 2, Issue 2, 2006, Pages 188-192

  Czeizel, Andrew E ^a   Puho, Erzsébe ^a   Acs, Nandor ^a   Banhidy, Ferenc ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Birth weight; Case control study; Congenital abnormalities; Low birth weight; Moroxydine

Indexed keywords

ANTIVIRUS AGENT; BIGUANIDE; MOROXYDINE; NORAMIDOPYRINE; PENAMECILLIN;

ANENCEPHALUS; ARTICLE; CASE CONTROL STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DOWN SYNDROME; DRUG USE; FEMALE; GENITAL HERPES; HUMAN; HUNGARY; INFLUENZA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; POPULATION RESEARCH; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PREVALENCE; QUESTIONNAIRE; RETROSPECTIVE STUDY; TABLET FORMULATION; TERATOGENICITY;

EID: 33646174037     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2006.188.192     Document Type: Article

References (27)

1. Ambro, Gy. and G. Nagy, 1974. Clinical testing of Morgalin Gyógyszereink, 24: 303-308.
2. Briggs, G.G., R.K. Freeman and S.J. Yaffe, 1998. Drugs in Pregnancy and Lactation. 5th Edn., Williams and Wilkins. Baltimore, pp: 493-494.
3. Czeizel, A.E., 1997. The first 25 years of the Hungarian congenital abnormality. Registry Teratology, 55: 299-305.
4. Czeizel, A.E., 1999. The role of pharmacoepidemiology in pharmacovigilance. Rational drug use in pregnancy. Pharma. Drug Safe., 8: 555-561.
5. Czeizel, A.E. and M. Rockenbauer, 2001. The ethical issues of the postmarketing surveillance of drug teratogenicity in Hungary. Pharma. Drug Safe., 10: 638-639.
6. Czeizel, A.E., M. Rockenbauer, Cs Siffel and E. Varga, 2001. Description and mission evaluation of the Hungarian Case-control Surveillance of Congenital Abnormalities. Teratology, 63: 176-185.
7. Czeizel, A.E., D. Petik and P. Vargha, 2003. Validation studies of drug exposures in pregnant women. Pharma. Drug Safe., 12: 409-16.
8. Denno, K.M. and T.W. Sadler, 1994. Effects of the biguanide class of oral hypoglemic agents on mouse embriogenesis. Teratology, 49: 260-266.
9. Duperrat, B. and G. Goudie, 1962. Giant aphthosis of the penis treated by virostat. Bull. Soc. Franc. Derm. Syph., 69: 901-902.
10. Farago, L. and K. Bálint, 1969. The treatment with Morgalin of skin diseases of viral origin Gyógyszereink, 19: 203-205.
11. Friedman, J.M. and J.E. Dolifka, 1996. The Effect of Drugs on the Fetus and Nursing Infant. Johns Hopkins Univ. Press. Baltimore.
12. Goetzee, E.J. and W.P.U. Jackson, 1984. Oral hypoglycemics in the first trimester and fetal outcome. S. Afr. Med., 65: 635-637.
13. Kleinschmidt, H., 1962. Trials with ABOB for prevention and therapy of measles and chickenpox. Mundi Med Uschr., 104: 2294-2296.
14. Martinon J. and L. Baran, 1964. Une varicelle a l'heure du virostat. Bull. Soc. Franc. Derm., 71: 92-93.
15. Márton, K., 1976. Symptomatology and epidemiology of molluscum contagiosum in Africa and its effective treatment with Morgalin Borgyógyászati és Venerológiai Szemle, 52: 262-268.
16. Melander, B., 1960. Flumidin in experimental and clinical respiratory viruses. Arzneimittel-Forschung, 10: 319-320.
17. 1-anhydrobis (β-hydroxyethyl) biguanide-HCl (AB0B). Toxicol. Applied Pharmacol., 2: 474-89.
18. Mészáros, Cs., 1970. The effect of Morgalin in the treatment of viral skin diseases Gyógyszereink, 20: 207-210.
19. Nagy, M., 1971. The treatment of adenopharyngeo-conjunctivitis with Morgalin Gyógyszereink, 21: 269-270.
20. Nasemann, Th., 1962. Virustatic effect of a heterocyclic biguanide on herpes simplex virus in vitro. Hautarzt, 13: 182-185.
21. Pettersson, F.L. Olding and K.H. Gustavson, 1970. Multiple severe malformations in a child of a diabetic mother threated with insulin and dibein during pregnancy. Acta. Obstet. Gynec Scand., 49: 385.
22. Product Information, 1977. Glucophage cit Briggs et al., 1998. Bristol-Myers. Squibb, 1977.
23. Rivoire, J., 1963. Action of N1-N1 anhydrobis- (β-hydroxyethyl) biguadine HCl on certain dermatological disorders of viral origin. Bull. Soc. Franc. Derm., 70: 94-95
24. Schersten, B., 1959. Herpes zoster treated with N1, N1-anhydrobis (2-hydroxyetzhyl)-biguadine HCl (ABOB). Svenska Lakarstidn, 56: 3563-3566.
25. Shepard, T.H., 1998. Catalog of Teraogenic Agents. 9th Edn., The Johns Hopkins Univ Press. Baltimore.
26. Sjöberg, B., 1960. ABOB, a new chemotherapeutic principle in prevention and suppression of clinical influenza. Münche Med Wschr., pp: 485.
27. Tuchmann-Dupless, H. and L. Mercier-Parot, 1961. Repercussions sur la gestation et le développement foetal du rat d'un hypoglycémiant, le chlorhydrate de N,N-dimethylbiguanide. C. R. Acad. Sci., 253: 321-323.